The International Centre for Cell Therapy and Cancer Immunotherapy provides patients with innovative, personalized cell therapy and immunotherapy for the treatment of cancer and autoimmune diseases. Regenerative therapies developed at the Centre achieve promising results in neurological diseases and other disorders.
The Institute is headed by Professor Shimon Slavin, who has international recognition for his innovative use of cell therapy and immunotherapy in the treatment of cancer and life-threatening non-malignant diseases.
His ground-breaking work in cancer cell therapy using donor lymphocyte infusions (DMI), post allogeneic stem cell transplantation and non-myeloablative stem cell transplantation (NST) is now used worldwide. Nonmyeloablative stem cell transplantation is much safer, easier for the patient and more economical compared to previously developed procedures. He has also developed personalized approaches to cancer treatment using immunotherapy through innovative targeted cell therapy and vaccines; for immune regulation of autoimmune diseases; and to promote transplant tolerance to bone marrow and organ allografts. Professor Slavin introduced the use of multipotent stem cells for regenerative medicine, focusing on suppression of self-activating lymphocytes and repair of damaged tissues and organs.